0.03 (1.33%) 1d
He's shocked this is so low. Glaxo should buy them. At $2, the risk is priced in. Buy.
It's a genetic testing company with subscription services to let you know how your genes could effect your health. They went public last June, but has fallen since from $11 to $8. He doesn't understand why. Gene sequencing is the future of medicine and this company holds a treasure trove of data (kept private) that could be applied in medicine.
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

23andMe(ME-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for 23andMe is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

23andMe(ME-Q) Frequently Asked Questions

What is 23andMe stock symbol?

23andMe is a American stock, trading under the symbol ME-Q on the NASDAQ (ME). It is usually referred to as NASDAQ:ME or ME-Q

Is 23andMe a buy or a sell?

In the last year, 1 stock analyst published opinions about ME-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for 23andMe.

Is 23andMe a good investment or a top pick?

23andMe was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for 23andMe.

Why is 23andMe stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is 23andMe worth watching?

In the last year, there was no coverage of 23andMe published on Stockchase.

What is 23andMe stock price?

On 2023-03-31, 23andMe (ME-Q) stock closed at a price of $2.28.